These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

110 related articles for article (PubMed ID: 3288743)

  • 1. Correlation between the sterol composition of membranes and morphology in Candida albicans.
    Cannon RD; Kerridge D
    J Med Vet Mycol; 1988 Feb; 26(1):57-65. PubMed ID: 3288743
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Dimorphism-associated variations in the lipid composition of Candida albicans.
    Ghannoum MA; Janini G; Khamis L; Radwan SS
    J Gen Microbiol; 1986 Aug; 132(8):2367-75. PubMed ID: 3540201
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A comparison of the sterol content of multiple isolates of the Candida albicans Darlington strain with other clinically azole-sensitive and -resistant strains.
    Howell SA; Mallet AI; Noble WC
    J Appl Bacteriol; 1990 Nov; 69(5):692-6. PubMed ID: 2276986
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Lipid content and ESR determination of plasma membrane order parameter in Candida albicans sterol mutants.
    Pesti M; Horváth L; Vígh L; Farkas T
    Acta Microbiol Hung; 1985; 32(4):305-13. PubMed ID: 3012928
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The lipid composition and permeability to the triazole antifungal antibiotic ICI 153066 of serum-grown mycelial cultures of Candida albicans.
    Hitchcock CA; Barrett-Bee KJ; Russell NJ
    J Gen Microbiol; 1989 Jul; 135(7):1949-55. PubMed ID: 2693607
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Variation in lipid and sterol contents in Candida albicans white and opaque phenotypes.
    Ghannoum MA; Swairjo I; Soll DR
    J Med Vet Mycol; 1990; 28(2):103-15. PubMed ID: 2199656
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Correlation of inhibition of sterol synthesis with growth-inhibitory action of imidazole antimycotics in Candida albicans.
    Nicholas RO; Kerridge D
    J Antimicrob Chemother; 1989 Jan; 23(1):7-19. PubMed ID: 2663807
    [TBL] [Abstract][Full Text] [Related]  

  • 8. In vitro and in vivo effects of the antimycotic drug ketoconazole on sterol synthesis.
    Van den Bossche H; Willemsens G; Cools W; Cornelissen F; Lauwers WF; van Cutsem JM
    Antimicrob Agents Chemother; 1980 Jun; 17(6):922-8. PubMed ID: 6250469
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Change in the composition of Candida albicans cells during development of resistance to polyene antibiotics].
    Virina AM; Feĭgin AM; Belousova II; Tereshin IM
    Mikrobiologiia; 1976 JUL-AUG; 45(4):679-84. PubMed ID: 790101
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Subinhibitory concentration of octenidine and pirtenidine: influence on the lipid and sterol contents of Candida albicans.
    Ghannoum MA; Moussa NM; Whittaker P; Swairjo I; Abu-Elteen KH
    Chemotherapy; 1992; 38(1):46-56. PubMed ID: 1618003
    [TBL] [Abstract][Full Text] [Related]  

  • 11. In vitro susceptibility and sterol biosynthesis of Candida albicans strains after long-term treatment with azoles in HIV-infected patients.
    Hundt W; Hofmann H
    Infection; 1994; 22(2):124-31. PubMed ID: 8070926
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Cross-resistance of Candida albicans to several different families of antifungals with ergosterol biosynthesis-inhibiting activity].
    Hiratani T; Yamaguchi H
    Jpn J Antibiot; 1994 Feb; 47(2):125-8. PubMed ID: 8151906
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Reduced azole susceptibility of oral isolates of Candida albicans from HIV-positive patients and a derivative exhibiting colony morphology variation.
    Gallagher PJ; Bennett DE; Henman MC; Russell RJ; Flint SR; Shanley DB; Coleman DC
    J Gen Microbiol; 1992 Sep; 138(9):1901-11. PubMed ID: 1402791
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of terconazole and other azole antifungal agents on the sterol and carbohydrate composition of Candida albicans.
    Pfaller MA; Riley J; Koerner T
    Diagn Microbiol Infect Dis; 1990; 13(1):31-5. PubMed ID: 2184984
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Inhibition of germ tube formation, filamentation and ergosterol biosynthesis in Candida albicans treated with 6-amino-2-n-pentylthiobenzothiazole.
    Fábry S; Gáborová S; Bujdáková H; Klobusický M; Volleková A; Kuchta T
    Folia Microbiol (Praha); 1999; 44(5):523-6. PubMed ID: 10997135
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Inhibitory effect of terbinafine on reactive oxygen species (ROS) generation by Candida albicans.
    Sander CS; Hipler UC; Wollina U; Elsner P
    Mycoses; 2002 Jun; 45(5-6):152-5. PubMed ID: 12100530
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of sub-inhibitory concentration of chlorhexidine on lipid and sterol composition of Candida albicans.
    Abu-Elteen KH; Whittaker PA
    Mycopathologia; 1997-1998; 140(2):69-76. PubMed ID: 9646510
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of squalene epoxidase inhibitors on Candida albicans.
    Georgopapadakou NH; Bertasso A
    Antimicrob Agents Chemother; 1992 Aug; 36(8):1779-81. PubMed ID: 1416865
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Disruption of ergosterol biosynthesis, growth, and the morphological transition in Candida albicans by sterol methyltransferase inhibitors containing sulfur at C-25 in the sterol side chain.
    Kanagasabai R; Zhou W; Liu J; Nguyen TT; Veeramachaneni P; Nes WD
    Lipids; 2004 Aug; 39(8):737-46. PubMed ID: 15638241
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Sterols in Candida albicans mutants resistant to polyene or azole antifungals, and of a double mutant C. albicans 6.4.
    Hitchcock CA; Russell NJ; Barrett-Bee KJ
    Crit Rev Microbiol; 1987; 15(1):111-5. PubMed ID: 3319418
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.